Past performance
Performance overview
About Aakaar Medical Technologies Ltd Aakaar Medical Technologies Limited, initially established in 2013 as a private entity, transitioned to a public limited company in November 2024. The company specializes in medical aesthetics, offering a diverse portfolio of aesthetic and specialized cosmetic products and devices. Its key customers include dermatologists, plastic surgeons, and aesthetic physicians who use these devices in treatments or sell associated products to end consumers. The company markets both its own brands—comprising domestically manufactured products and internationally sourced devices—and imported brands distributed from countries like South Korea, Spain, Italy, and Austria. Notable own-brand launches include Tubelite, Balback, Lytec, Etrelume, Swyada, Exoluxe, DRS1512, and Eoluxe, demonstrating Aakaar's consistent innovation in product offerings. A pivotal agreement with South Korea's Medytox Inc. in 2016 facilitated the launch of Siax, a key milestone in its international collaborations. To fuel its growth trajectory, Aakaar Medical Technologies is preparing for an Initial Public Offering (IPO), aiming to issue 3,750,400 equity shares with a face value of Rs. 10 each through a fresh issue. This move is expected to provide the company with additional resources to expand its operations and strengthen its market position in the fast-growing medical aesthetics industry. Aakaar's diversified product range, strategic international partnerships, and consistent innovation make it a relevant player in the cosmetic and aesthetic device sector. Its planned IPO signals a commitment to growth and market leadership, presenting an intriguing opportunity for traders and investors.
Website aakaarmedical.in
Founded 2013
Headquarters Mumbai